Article Information
- Received July 30, 2002
- Revision received April 14, 2003
- Accepted April 15, 2003
- First published July 2, 2003.
- Version of record published July 2, 2003.
Author Information
- Thomas Oertle1,*,
- Marjan E. van der Haar1,*,
- Christine E. Bandtlow2,
- Anna Robeva3,
- Patricia Burfeind3,
- Armin Buss1,
- Andrea B. Huber1,
- Marjo Simonen1,
- Lisa Schnell1,
- Christian Brösamle1,
- Klemens Kaupmann4,
- Rüdiger Vallon3, and
- Martin E. Schwab1
- 1Brain Research Institute, University of Zurich, and Department of Biology, Swiss Federal Institute of Technology, CH-8057 Zurich, Switzerland, 2Institute of Medical Chemistry and Biochemistry, Leopold-Franzens-University of Innsbruck, A-6020 Innsbruck, Austria, 3Novartis Institute for Biomedical Research, Functional Genomics, Novartis Pharmaceuticals Corporation, Summit, New Jersey 07901, and 4Novartis Pharma AG, Nervous System Research, CH-4002 Basel, Switzerland
Author contributions
Disclosures
- Received July 30, 2002.
- Revision received April 14, 2003.
- Accepted April 15, 2003.
This study was supported by the Swiss National Science Foundation (Grant 31-63633) and by the Spinal Cord Consortium of the Christopher Reeve Paralysis Foundation, Springfield, NJ. We thank B. Haudenschild, T. Flego, F. Christ, B. Niederöst, and C. Huber for excellent technical assistance, Dr. B. Martoglio for helpful discussions, and R. Schöb for help with the figures. Special thanks to Dr. M. Zurini (Novartis Pharma) for HPLC purification and PreScission cleavage of GST-Nogo-66 and Superdex Gel filtration of NiG, Dr. B. Sommer (Novartis Pharma) for hNogo-A cDNA, Dr. M. Chao for kindly providing us with the APtag5 vector, and Dr. R. Giger for providing us with the AP-Sema3A vector.
Correspondence should be addressed to Thomas Oertle, Department of Biology, Swiss Federal Institute of Technology Zurich and Brain Research Institute, University of Zurich, CH-8057 Zurich, Switzerland. E-mail: oertle{at}hifo.unizh.ch.
A. B. Huber's present address: Department of Neuroscience, The Johns Hopkins School of Medicine, Baltimore MD, 21205.
M. Simonen's present address: Novartis Pharma AG, CH-4002 Basel, Switzerland.
C. Brösamle's present address: Department of Embryology, Carnegie Institution of Washington, Baltimore MD, 21210.
Copyright © 2003 Society for Neuroscience 0270-6474/03/235393-14$15.00/0
↵* T.O. and M.E.V. contributed equally to this work.
Online Impact